Skip to main content
. 2017 Apr 28;37(2):BSR20160556. doi: 10.1042/BSR20160556

Table 1.

Nucleotide sequences of primers used in the present study

Primer name Sequences (5′–3′) Restriction sites
hGHpA-F GGAACCTGCAGGGATCCACGGGTGGCATCCCTGT PstI, BamHI
hGHpA-R GGAACCTCGAGAAGGACAGGGAAGGGAG XhoI
iRFP-F GGAACGTCGACGCCACCATGGCGGAAGGATCCGT SalI
iRFP-R GGAACAGATCTTCACTCTTCCATCACGC BglII
MCS+ GATCTGTACACTAGTTTAAACCGGTCGACGGWCCGTACGGCGCGCCTAGGGCCCGGCCGGCC TTAAGCGCTAGCGATC BsrGI, SpeI, PmeI, AgeI, RsrII, BsiwI, AscI, AvrII, ApaI, SfiI, FseI, AfeI, NheI, BmtI
MCS- GATCGATCGCTAGCGCTTAAGGCCGGCCGGGCCCTAGGCGCGCCGTACGGWCCGTCGACC GGTTTAAACTAGTGTACA BsrGI, SpeI, PmeI, AgeI, RsrII, BsiwI, AscI, AvrII, ApaI, SfiI, FseI, AfeI, NheI, BmtI
CMV promoter-F GGAACAGATCTACGCGTGGAGCTAGTTAT BglII
CMV promoter-R GGAACAGATCTTCCCAATTCTTTGCCAAAGT BglII
TRAIL-F GGAACAGCGCTGCCACCATGGCTATGATGGAGGT AfeI
TRAIL-R GGAACAGATCTTTAGCCAACTAAAAAGG AfeI